University of Leeds: Arthritis trials

The registry lists 13 Arthritis studies with University of Leeds as lead sponsor. 0 are open to participants now and 1 have results posted.

Phase 2 3Phase 4 6No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Seronegative Oligoarthritis of the Knee Study (SOKS)TerminatedNCT01216631Phase 2Results posted
• Dietary Factors and Rheumatoid Arthritis Risk in the UK BiobankActive, not recruitingNCT06670183
• Diet and Rheumatoid Arthritis Risk in the United Kingdom Women's CohortCompletedNCT06670144
• Ticopa Serum Analysis: an Analysis of Blood Samples From the TICOPA StudyStatus unknownNCT05329896
• Abatacept in Individuals Who aRe Considered At Risk of Developing Inflammatory ArthritisTerminatedNCT04261023Phase 2
• Tocilizumab REMission in Early RACompletedNCT04157010Phase 4
• ADalimumab in Persistent Early Oligoarthrits Study (ADEOS)CompletedNCT04154852Phase 2
• Targeted Treatment Early With Etanercept + Methotrexate vs.T2T Care for DMARD-naïve Early RA Patients Based on naïve T-cell StratificationStatus unknownNCT03813771Phase 4
• Very Early Versus Delayed Etanercept in Patients With RACompletedNCT02433184Phase 4
• Targeted Ultrasound in Rheumatoid ArthritisCompletedNCT02056184Phase 4
• The CCP Study: Coordinated Programme to Prevent Arthritis - Can We Identify Arthritis at a Pre-clinical Stage ?Active, not recruitingNCT02012764
• Infliximab as Induction Therapy in Early Rheumatoid Arthritis (IDEA)CompletedNCT01308255Phase 4
• Etanercept and Methotrexate in Patients to Induce Remission in Early Arthritis (EMPIRE)CompletedNCT01303874Phase 4